natural remedies · Ingredient
(-)-huperzine a
Formula: C15H18N2O · MW: 242.322 · Drug-likeness: 0.684
⚗️ Identity
Name
(-)-huperzine a
Aliases / Synonyms
Huperzine A; 102518-79-6; (-)-Selagine; Fordine; HuperzineA; 120786-18-7; C15H18N2O; (1R,9R)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,10-trien-5-one; (1R,9R,13Z)-1-Amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,10-trien-5-one
🧪 Chemistry
Molecular Weight
242.3220
LogP
1.9975
Drug-likeness
0.684
H-Bond Acceptors
2
H-Bond Donors
2
🔗 External References
0
Clinical Trials
5
Meta-Analyses
0
PubMed References
Top Conditions Studied with (-)-huperzine a
📋 Sample Trials
None linked yet.
📊 Sample Meta-Analyses
CRD42015024796
Huperzine A for major depressive disorder: a review of the literature
Huperzine A, an alkaloid initially identified from the Chinese herbal medicine H
CRD42015024198
Huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis
Huperzine A, an alkaloid initially identified from the Chinese herbal medicine H
CRD42015023354
Comparative efficacy and safety of Huperzine A and Ginkgo biloba extract in patients with Alzheimer’s disease: a network meta-analysis of randomized controlled trials
Alzheimer disease
CRD42012003249
Huperzine A preparation for Alzheimer’s disease: a systematic review and meta-analysis of randomized clinical trials
Alzheimer’s disease, first described by German psychiatrist Alois Alzheimer in 1
CRD42020168194
Effects of Huperzine A on Dementia and Mild Cognitive Impairment: an Overview of Systematic Reviews
Dementia (Alzheimer’s disease or Vascular dementia) or Mild Cognitive Impairment
📚 Sample References
None linked yet.